KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Factset Research Systems (FDS) EBT (2016 - 2025)

Historic EBT for Factset Research Systems (FDS) over the last 17 years, with Q4 2025 value amounting to $190.1 million.

  • Factset Research Systems' EBT rose 577.17% to $190.1 million in Q4 2025 from the same period last year, while for Nov 2025 it was $731.3 million, marking a year-over-year increase of 1147.57%. This contributed to the annual value of $721.0 million for FY2025, which is 1066.07% up from last year.
  • Factset Research Systems' EBT amounted to $190.1 million in Q4 2025, which was up 577.17% from $189.0 million recorded in Q3 2025.
  • Factset Research Systems' EBT's 5-year high stood at $190.5 million during Q2 2024, with a 5-year trough of $85.3 million in Q2 2022.
  • For the 5-year period, Factset Research Systems' EBT averaged around $146.9 million, with its median value being $157.3 million (2022).
  • In the last 5 years, Factset Research Systems' EBT tumbled by 2537.37% in 2022 and then skyrocketed by 8996.01% in 2023.
  • Over the past 5 years, Factset Research Systems' EBT (Quarter) stood at $119.9 million in 2021, then surged by 31.65% to $157.9 million in 2022, then increased by 10.96% to $175.2 million in 2023, then grew by 2.59% to $179.7 million in 2024, then rose by 5.77% to $190.1 million in 2025.
  • Its last three reported values are $190.1 million in Q4 2025, $189.0 million for Q3 2025, and $179.9 million during Q2 2025.